Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease
Florence T.H. Wu(University of Toronto), Robert S. Kerbel(Sunnybrook Health Science Centre)
Cited by 46
Related Papers
Tumor angiogenesis: past, present and the near future
|Carcinogenesis|2000|971
Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy <i>in vitro</i>
|Molecular Cancer Therapeutics|2004|104
<i>In vitro</i> Procoagulant Activity Induced in Endothelial Cells by Chemotherapy and Antiangiogenic Drug Combinations: Modulation by Lower-Dose Chemotherapy
|Cancer Research|2005|75
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer
|npj Breast Cancer|2020|40
Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents
|Molecular Cancer Therapeutics|2005|38